Chengai Wu

机构：Capital Medical University, Peking University, Beijing Jishuitan Hospital · ORCID：0000-0002-6366-4758

发表论文 40 篇 · 总被引 1103 次 · h-index 16

代表论文

• A Cell‐Free Silk Fibroin Biomaterial Strategy Promotes In Situ Cartilage Regeneration Via Programmed Releases of Bioactive Molecules (2022 · Advanced Healthcare Materials · 被引 45)
• The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression (2024 · Bone and Joint Research · 被引 14)
• Eugenol protects chondrocytes and articular cartilage by downregulating the JAK3/STAT4 signaling pathway (2022 · Journal of Orthopaedic Research® · 被引 13)
• Identification and verification of four candidate biomarkers for early diagnosis of osteoarthritis by machine learning (2024 · Heliyon · 被引 12)
• A Cell‐Free Silk Fibroin Biomaterial Strategy Promotes In Situ Cartilage Regeneration Via Programmed Releases of Bioactive Molecules (2023 · Advanced Healthcare Materials · 被引 11)
• Differential proteomic analysis of tibial subchondral bone from male and female guinea pigs with spontaneous osteoarthritis (2021 · Experimental and Therapeutic Medicine · 被引 11)